Molecular Partners raised CHF 18.5m in Series A Equity Financing Round
Swiss-based biotechnology firm Molecular Partners AG raised CHF 18.5 million in a series A equity investment round which closed in August 2007. The investment round and syndicate of investors were led by European venture capitalist Index Ventures and included BB Biotech Ventures, Johnson & Johnson Development Corporation and Endeavour.
Molecular Partners was advised by Lenz & Staehelin. Lenz & Staehelin's team included Beat Kühni and Dominik Kaczmarczyk